Drug
Dual Target Car NK Cells
Dual Target Car NK Cells: highest development phase Phase 1, developed by Beijing Biotech. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Beijing Biotech
Trials
| Drug | Phase | Indication |
|---|---|---|
| Dual-target CAR-NK cells NCT07551336 | Phase 1 | Malignant Glioma |
| Dual-target CAR-NK cells NCT07480941 | Phase 1 | Glioblastoma |
Latest
No recent events.
Follow Dual Target Car NK Cells on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.